OAM
IMGN

Oxford Asset Management’s Immunogen Inc IMGN Stock Holding History

Oxford Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,857
Closed -$559K – 386
2023
Q4 		$559K Buy
+18,857
New +$376K 0.84% 31
2020
Q1 		– Sell
-348,014
Closed -$1.78M – 1449
2019
Q4 		$1.78M Sell
348,014
-20,743
-6% -$70.4K 0.05% 493
2019
Q3 		$892K Buy
+368,757
New +$979K 0.02% 996
2019
Q1 		– Sell
-413,953
Closed -$1.99M – 2073
2018
Q4 		$1.99M Buy
+413,953
New +$2.51M 0.05% 467
2018
Q2 		– Sell
-132,882
Closed -$1.4M – 1979
2018
Q1 		$1.4M Sell
132,882
-87,263
-40% -$862K 0.03% 769
2017
Q4 		$1.46M Buy
+220,145
New +$1.36M 0.03% 745
2017
Q3 		– Sell
-71,166
Closed -$506K – 1751
2017
Q2 		$506K Buy
+71,166
New +$326K 0.01% 1116
2016
Q1 		– Sell
-172,693
Closed -$2.36M – 923
2015
Q4 		$2.36M Buy
+172,693
New +$2.13M 0.06% 364
2013
Q3 		– Sell
-63,160
Closed -$1.05M – 924
2013
Q2 		$1.05M Buy
+63,160
New +$1.02M 0.03% 585

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Oxford Asset Management's IMGN Position: Q1 2024 in Review

Oxford Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 18,857 shares — an estimated $559K sold.

Oxford Asset Management first reported a position in IMGN in Q2 2013 and held it in 9 quarters. The position peaked at $2.36M in Q4 2015. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Oxford Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Oxford Asset Management sold 18,857 Immunogen Inc shares in Q1 2024, an estimated $559K.
  • Oxford Asset Management first reported a position in Immunogen Inc in Q2 2013 and held it in 9 quarters.
  • Oxford Asset Management's Immunogen Inc position peaked at $2.36M in Q4 2015.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Oxford Asset Management's 13F filing for Q1 2024, filed 15 May 2024.